Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » NNGY - Nanergy, Inc. » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
YellowSubmarine  - posted
[b]Nanergy Corporation (Pink NNGY):[/b] We focus our nanotechnology research on the use of single walled and multiwalled carbon nanotubes for hydrogen storage. In cooperation with our research partners at the the University of Szeged in Hungary and Tsinghua University in China, we make our carbon nanotubes optimized to our particular applications.
[b]Website:[/b] http://www.nanergycorp.com/ ........ [b]IR:[/b] http://www.demonte.com/
 
YellowSubmarine  - posted
[i][b]Nanergy To Host Investor Teleconference; Management to Report on Current Status and Forward Momentum[/b]
7/8/2005 3:16:01 PM[/i]

[b]NEW YORK, Jul 08, 2005 (BUSINESS WIRE) -- Nanergy Inc. ("Nanergy"), formerly ObjectSoft Corp. (OTC Other: NNGY, formerly OSFT) today announced that management will conduct an investor teleconference to update shareholders concerning the Company's current status and strategic initiatives.[/b]

The objective of this live teleconference is to keep shareholders current concerning the mission of the Company. Shareholders will be updated with the date and time of the call within one week.

Nanergy is entering the nanotechnology and alternative energy arenas - both areas of burgeoning growth as the world's energy crisis escalates and government's focus is on sources of fuel and energy and the demand for nanoscale devices is growing at 30.6% annually.

From an industry perspective, BCC Research reported that the total global demand for nanoscale materials, tools, and devices was estimated at $7.6 billion in 2003 and is expected to grow at an AAGR (average annual growth rate) of 30.6% to reach $28.7 billion in 2008. Comparing nanotechnology to other key emerging technologies, the global nanotechnology market, at about $7 billion in 2002, was roughly comparable in size to the biotechnology sector, but far smaller than the $800 billion global informatics market. However, the nanotechnology market is believed to be growing more than twice as fast as either of the other two.

The nanomaterials segment, which includes several long-established markets such as carbon black rubber filler, catalytic converter materials and silver nanoparticles used in photographic films and papers, presently accounts for over 97.5% of global nanotechnology sales. By 2008, the nanomaterials share of the market will have shrunk to 74.7% of total sales. Nanotools will have increased their share to 4.3% ($1.2 billion), and nanodevices will have established a major presence in the market with a 21% share ($6.0 billion).

Nanoparticles currently account for the largest share of the nanomaterials market. However, the fastest-growing nanomaterials segments are nanotubes (with a projected AAGR of 173% over the next five years) and nanocomposites (76% AAGR).

Other trends, it is believed, will contribute to the future growth of the nanotechnology sector, including high levels of government support for nanotechnology R&D (estimated at over $2.2 billion in 2002, alone) and growing venture capital investments in nanotechnology companies, which have increased sixfold over the past two years.

Management plans to conduct shareholder teleconferences on a regular basis update shareholders and potential investors.

About Nanergy Inc.

Nanergy Inc. is a developmental stage company headquartered in New York City, with offices in Princeton, NJ and in Hungary. Its focus is on developing exciting consumer products that harness nanotechnology, and especially photovoltaic nanofilms, while conducting ongoing research in storing hydrogen using carbon nanotubes. Its new corporate website is still being developed but is available for viewing at http://www.nanergyinc.com.

SOURCE: Nanergy Inc.
Investors:
DeMonte Associates
Cynthia DeMonte, 212-605-0525
cdemonte@aol.com
www.demonte.com
.
 
Murnak  - posted
Looks like time to accumulate!
 
YellowSubmarine  - posted
Nanergy Inc. Announces the Appointment of Dr. Zoltan Kiss as President, Chief Executive Officer and Chairman; Dr. Kiss to Host Investor Conference Call on 8/15 at 12:00 PM EDT to Report on Current Status and Forward Momentum
8/3/2005 9:48:02 AM


NEW YORK, Aug 03, 2005 (BUSINESS WIRE) -- Nanergy Inc. ("Nanergy"), formerly ObjectSoft Corp. (OTC Other: NNGY, formerly OSFT) today announced that Dr. Zoltan Kiss, a world renowned scientist, has been appointed President, Chief Executive Officer and Chairman of the Board of Directors.

Dr. Kiss is one of the chief inventors of the digital watch, and has over 30 patents to his credit, including fundamental nanotechnology patents which were acquired by Nanergy when it purchased the nanotechnology assets of RES. Mr. Moshe Gluzman will remain with the company as Senior Vice President for Government Affairs and Corporate Secretary.

The Company will conduct an investor teleconference on August 15th at 12:00 PM EDT to update shareholders concerning the Company's current status, products, financing and strategic initiatives.

To access the conference, please dial 866-295-5950 and enter participant passcode 71056#. A recorded version of the conference will be posted on the Company's website at www.nanergyinc.com as soon as possible after the conference.

Management plans to conduct shareholder teleconferences on a regular basis update shareholders and potential investors.

Nanergy is entering the nanotechnology and alternative energy arenas - both areas of burgeoning growth as the world's energy crisis escalates and government's focus is on sources of fuel and energy and the demand for nanoscale devices is growing at 30.6% annually.

From an industry perspective, BCC Research reported that the total global demand for nanoscale materials, tools, and devices was estimated at $7.6 billion in 2003 and is expected to grow at an AAGR (average annual growth rate) of 30.6% to reach $28.7 billion in 2008. Comparing nanotechnology to other key emerging technologies, the global nanotechnology market, at about $7 billion in 2002, was roughly comparable in size to the biotechnology sector, but far smaller than the $800 billion global informatics market. However, the nanotechnology market is believed to be growing more than twice as fast as either of the other two.

About Nanergy Inc.

Nanergy Inc. is a developmental stage company headquartered in New York City, with offices in Princeton, NJ and in Hungary. Its focus is on developing exciting consumer products that harness nanotechnology, and especially photovoltaic nanofilms, while conducting ongoing research in storing hydrogen using carbon nanotubes. Its new corporate website is still being developed but is available for viewing at http://www.nanergyinc.com.

SOURCE: Nanergy Inc.
DeMonte Associates
Investors:
Cynthia DeMonte, 212-605-0525
cdemonte@aol.com
www.demonte.com
.
 
YellowSubmarine  - posted
Nanergy Inc. to Brief Shareholders on Product Plans; Dr. Kiss to Host Investor Conference Call on 8/15 at 12:00 pm EDT
8/10/2005 7:30:03 AM [/i]

NEW YORK, Aug 10, 2005 (BUSINESS WIRE) -- Nanergy Inc. ("Nanergy") (OTC Other: NNGY), today announced that Dr. Zoltan Kiss, who will become President effective Sept. 1, will brief investors on Nanergy's product development plans, patent status, schedule for availability of production prototypes, initial production, marketing thrust and financing during a call-in investor conference to be held on August 15th, at 12:00 EDT.

To access the conference, please dial 866-295-5950 and enter participant passcode 71056#. A recorded version of the conference will be posted on the Company's website at www.nanergyinc.com as soon as possible after the conference.

Management plans to conduct shareholder teleconferences on a regular basis update shareholders and potential investors.

About Nanergy Inc.

Nanergy Inc. is a developmental stage company headquartered in New York City, with offices near Princeton, NJ at 4260 Rt 1, Suite 7, Monmouth Junction, NJ 08852 (Tel 732 329-0045) as well as in Hungary. Its focus is on developing exciting consumer products that harness nanotechnology, and especially photovoltaic nanofilms, while conducting ongoing research in storing hydrogen using carbon nanotubes. Its new corporate website is still being developed but is available for viewing at http://www.nanergyinc.com.

SOURCE: Nanergy Inc.
DeMonte Associates
Investors:
Cynthia DeMonte, 212-605-0525
cdemonte@aol.com
www.demonte.com
.
 
Murnak  - posted
Time to grab a few more shares at this price!
 
rpmacs  - posted
nice upward movement today, currently at .30
 
Murnak  - posted
Gotta like this!

about time and away we go....
 
Murnak  - posted
Nice move today...volume should be picking up!

http://stockcharts.com/def/servlet/SC.web?c=nngy,uu[h,a]daclyyay[dd][pb5!b18][vc60][iUb9!La12,26,9]&pref=G
 
Murnak  - posted
This ship is sailing!

way to.................go!
 
charger  - posted
running again today
 
Murnak  - posted
Wow! here we go again!
 
Murnak  - posted
conference call!

Nanergy Inc. to Brief Shareholders on Product Plans
Wednesday August 10, 7:30 am ET
Dr. Kiss to Host Investor Conference Call on 8/15 at 12:00 pm EDT


NEW YORK--(BUSINESS WIRE)--Aug. 10, 2005--Nanergy Inc. ("Nanergy") (OTC Other: NNGY), today announced that Dr. Zoltan Kiss, who will become President effective Sept. 1, will brief investors on Nanergy's product development plans, patent status, schedule for availability of production prototypes, initial production, marketing thrust and financing during a call-in investor conference to be held on August 15th, at 12:00 EDT.
To access the conference, please dial 866-295-5950 and enter participant passcode 71056#. A recorded version of the conference will be posted on the Company's website at www.nanergyinc.com as soon as possible after the conference.

Management plans to conduct shareholder teleconferences on a regular basis update shareholders and potential investors.
 
YellowSubmarine  - posted
NanoViricides Announces Progress in Development of FluCide-I Influenza Drug
'Bird Flu Drug Meeting in Vietnam Planned for December as International Concern Is Mounting that the Disease Could Mutate into a Major Killer'

9/20/2005 3:52:57 PM


NEW YORK, Sept. 20, 2005, Sep 20, 2005 (PRIMEZONE via COMTEX) -- NanoViricides, Inc. (Pink Sheets:NNVC) announced today that the Company is actively developing its first NanoViricide(tm) drug, "FluCide-I(tm)." The Company expects to commence studies in external laboratories within a matter of weeks to verify the drug's effectiveness and basic safety profile against the influenza virus. Animal studies as well as cell culture studies will be initiated.

The Company has accelerated its development of FluCide-I in order to have basic safety and efficacy data on the anti-influenza system when it meets in December with the Government of Vietnam's National Institute of Hygiene and Epidemiology ("NIHE"). NIHE is Vietnam's leading institute for the surveillance, control and prevention of infectious diseases. They have extended an invitation to the Company to discuss the use of the NanoViricide technology in the battle against bird flu.

Public health officials have emphasized the importance of Vietnam in the fight against the Asian Bird Flu. What happens in poor, densely populated Vietnam is critical in preventing a global avian flu pandemic.

Experts predict that if the virus mutates into a form that is easily transmitted between humans, and is not contained in Southeast Asia, it could quickly kill up to 7 million people globally.

WHO's Vietnam director Hans Troedsson in news sources has stated, "This is not a Vietnamese problem; this is a global public health problem where Vietnam is on the front line."

"Our first drug, FluCide-I(tm), is now entering internal testing prior to release to external laboratories for animal testing and related work 'said Dr. Anil Diwan, President of NanoViricides, Inc. "I believe that FluCide-I, which is based on the core NanoViricide(tm) technology accompanied by a proprietary ligand that is capable of attachment to Influenza A, Influenza B, and Influenza C virus subtypes, may have a substantially improved effectiveness over the existing drugs. One of the main reasons for our trip to Vietnam will be to create a strategy for developing the ligands that are specific for Bird Flu so that FluCide-I can be quickly redeveloped to be specific against that disease. That resulting new drug will be called AvianFlucide-I(tm)."

FluCide-I is being developed at present as a bronchial aerosol that carries the drug into the bronchial/pulmonary space which is the primary site of infection by influenza viruses.

Eugene Seymour, MD, CEO of NanoViricides, Inc., said, "The enormous threat to the health of the world's population by Bird Flu is finally being acknowledged. Public Health officials are now saying that it is not a question of 'if' but of 'when' the epidemic will explode out of Asia. Tamiflu(tm), a drug produced by Roche Laboratories, is currently the only available treatment. Major governments are now starting to place orders to keep stockpiles of Tamiflu within their borders. The Financial Times reported yesterday that the United States is in talks with Roche to buy a large amount of the drug, and that the contract could be worth $1 billion."

About NanoViricides -- http://www.nanoviricides.com

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. NanoViricides, Inc. has exclusive license in perpetuity for technologies developed by Theracour Pharma for the five virus types: HIV, HCV, Herpes, Asian (bird) flu and Influenza. A NanoViricide(tm) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. When a NanoViricide drug enters the patient's blood stream, each nanoscale micelle of the drug attacks and neutralizes circulating virus particles. Once this is done, the active pharmaceutical ingredient is injected into the virus particle by the NanoViricide micelle, destroying it completely. The company plans to develop novel NanoViricide drugs first against HIV and Influenza, and anticipates that it will license the products to major pharmaceutical companies.

This news release was distributed by PrimeZone, www.primezone.com
SOURCE: NanoViricides, Inc.
NanoViricides, Inc., New York
Leo Ehrlich
917-853-6440
leo@nanoviricides.com
Anil R. Diwan, Ph.D.
adiwan@snet.net

.
 
Murnak  - posted
Nanergy Inc. Issues Manufacturing Order For First Product and Obtains Financing
Tuesday September 27, 7:30 am ET


NEW YORK--(BUSINESS WIRE)--Sept. 27, 2005--Nanergy Inc. ("Nanergy") (OTC Other: NNGY), today announced that it had issued a manufacturing order and provided a letter of credit for its first commercial product, the Nanosign(TM) ever-charged illuminated address sign. Manufactured prototypes are expected within 60 days, and first customer shipments aree expected in January 2006.

Separately, the Company announced that it has entered into private placement agreements in the amount of $300,000, of which $150,000 has been funded and $150,000 is expected to be funded before the end of this month.

About Nanergy Inc.

Nanergy Inc. is a developmental stage company headquartered in New York City, with offices near Princeton, NJ at 4260 Rt 1, Suite 7, Monmouth Junction, NJ 08852as well as in Hungary. Its focus is on developing exciting consumer products that harness nanotechnology, and especially photovoltaic nanofilms, while conducting ongoing research in storing hydrogen using carbon nanotubes. Its new corporate website is still being developed but is available for viewing at http://www.nanergyinc.com.
 
YellowSubmarine  - posted
Nanergy Inc. Issues Manufacturing Order For First Product and Obtains Financing
9/27/2005 7:30:04 AM


NEW YORK, Sep 27, 2005 (BUSINESS WIRE) -- Nanergy Inc. ("Nanergy") (OTC Other: NNGY), today announced that it had issued a manufacturing order and provided a letter of credit for its first commercial product, the Nanosign(TM) ever-charged illuminated address sign. Manufactured prototypes are expected within 60 days, and first customer shipments aree expected in January 2006.

Separately, the Company announced that it has entered into private placement agreements in the amount of $300,000, of which $150,000 has been funded and $150,000 is expected to be funded before the end of this month.

About Nanergy Inc.

Nanergy Inc. is a developmental stage company headquartered in New York City, with offices near Princeton, NJ at 4260 Rt 1, Suite 7, Monmouth Junction, NJ 08852as well as in Hungary. Its focus is on developing exciting consumer products that harness nanotechnology, and especially photovoltaic nanofilms, while conducting ongoing research in storing hydrogen using carbon nanotubes. Its new corporate website is still being developed but is available for viewing at http://www.nanergyinc.com.

SOURCE: DeMonte Associates
DeMonte Associates
Cynthia DeMonte, 212-605-0525
cdemonte*aol.com

.
 
YellowSubmarine  - posted
Official Nanergy Gram...:

As Brian Wilson would often say, ..while lounging on the fender of his Beach Buggy.....

I'm staring to get those, "....Good, ...good, ...good --- good vibrations..........

.
 
YellowSubmarine  - posted
Nanergy Responds to Complaints Regarding Momentum Marketing
10/17/2005 7:30:01 AM

NEW YORK, Oct 17, 2005 (BUSINESS WIRE) -- Nanergy Inc. ("Nanergy") (OTC Other: NNGY), announced today that it has been receiving complaints from recipients of faxes that were purportedly disseminated by Momentum Marketing. The fax purports to describe Nanergy's business and predicts future performance of the Company's stock.

Management of the Company unequivocally disclaims authorship of the fax. The Company has no relationship with Momentum Marketing and has not authorized anyone to provide any such information to the public. The Company is actively and vigorously investigating this matter and is consulting with counsel to determine what legal actions and recourse are available to it to prevent renegade entities from engaging in further unauthorized and unsanctioned activities.

About Nanergy Inc.

Nanergy Inc. is a developmental stage company headquartered in New York City, with offices near Princeton, NJ at 4260 Rt 1, Suite 7, Monmouth Junction, NJ 08852 as well as in Hungary. Its focus is on developing exciting consumer products that harness nanotechnology, and especially photovoltaic nanofilms, while conducting ongoing research in storing hydrogen using carbon nanotubes. Its new corporate website is still being developed but is available for viewing at http://www.nanergyinc.com.

SOURCE: Nanergy Inc.
DeMonte Associates
Cynthia DeMonte, 212-605-0525
cdemonte*aol.com
.
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share